RANDOMIZED-3 ARMED PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/

GERHARTZ HH WALTHER JH NEUWIRTOVA R FENAUX P HAROUSSEAU JL BEKSAC M ZWIERZINA H BAUMELOU E FIERE D LOUWAGIE A THYSS A DARDENNE M SOLBU G SUCIU S ZITTOUN R

Hh. Gerhartz et al., RANDOMIZED-3 ARMED PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/, Blood, 88(10), 1996, pp. 2309-2309

NO

Hematology

Blood → ACNP

00064971

88

10

1996

1

1

2309 - 2309

ISI

0006-4971(1996)88:10<2309:RAPSOI>2.0.ZU;2-M